{
    "Trade/Device Name(s)": [
        "BD Veritor\u2122 System for Rapid Detection of Flu A+B"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K120049",
    "Predicate Device Reference 510(k) Number(s)": [
        "K053146",
        "K092698"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "GNX"
    ],
    "Summary Letter Date": "January 5, 2012",
    "Summary Letter Received Date": "January 6, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3330"
    ],
    "Regulation Name(s)": [
        "Influenza Serological Reagents"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology",
        "immunology"
    ],
    "Analyte(s)": [
        "Influenza A viral nucleoprotein antigen",
        "Influenza B viral nucleoprotein antigen"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal wash",
        "Nasopharyngeal aspirate"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        "BD Veritor\u2122 System Reader"
    ],
    "Method(s)/Technology(ies)": [
        "Chromatographic immunoassay",
        "Immunochromatography"
    ],
    "Methodologies": [
        "Qualitative antigen detection"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay",
        "Reader",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for BD Veritor System rapid chromatographic immunoassay for Influenza A and B antigen detection in nasopharyngeal washes/aspirates using an electronic reader.",
    "Indications for Use Summary": "Aid in the direct and qualitative detection and differentiation of influenza A and B viral nucleoprotein antigens in nasopharyngeal washes/aspirates from symptomatic patients to assist in diagnosis; negative results are presumptive and recommended to be confirmed by viral culture or FDA-cleared molecular assay; not intended for influenza C antigen detection.",
    "fda_folder": "Microbiology"
}